128 related articles for article (PubMed ID: 25303481)
41. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
Maeshima AM; Tsuta K; Asamura H; Tsuda H
Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
[TBL] [Abstract][Full Text] [Related]
42. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
[TBL] [Abstract][Full Text] [Related]
43. Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension.
Pellegriti G; Lumera G; Malandrino P; Latina A; Masucci R; Scollo C; Spadaro A; Sapuppo G; Regalbuto C; Pezzino V; Vigneri R
J Clin Endocrinol Metab; 2013 Feb; 98(2):458-65. PubMed ID: 23293327
[TBL] [Abstract][Full Text] [Related]
44. Papillary thyroid cancer: time course of recurrences during postsurgery surveillance.
Durante C; Montesano T; Torlontano M; Attard M; Monzani F; Tumino S; Costante G; Meringolo D; Bruno R; Trulli F; Massa M; Maniglia A; D'Apollo R; Giacomelli L; Ronga G; Filetti S;
J Clin Endocrinol Metab; 2013 Feb; 98(2):636-42. PubMed ID: 23293334
[TBL] [Abstract][Full Text] [Related]
45. A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study.
Abdollah F; Schmitges J; Sun M; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Prostate; 2011 Oct; 71(14):1587-94. PubMed ID: 21480307
[TBL] [Abstract][Full Text] [Related]
46. [Non-incidental papillary microcarcinomas of the thyroid].
Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
[TBL] [Abstract][Full Text] [Related]
47. [Differentiated thyroid carcinoma. Surgery and significance of lymph node involvement].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Chirurg; 2002 Jan; 73(1):38-43; discussion 43-5. PubMed ID: 11974460
[TBL] [Abstract][Full Text] [Related]
48. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
49. Metastasis to subsegmental and segmental lymph nodes in patients resected for non-small cell lung cancer: prognostic impact.
Rena O; Boldorini R; Papalia E; Turello D; Massera F; Davoli F; Roncon A; Baietto G; Casadio C
Ann Thorac Surg; 2014 Mar; 97(3):987-92. PubMed ID: 24480258
[TBL] [Abstract][Full Text] [Related]
50. The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection.
Giles Senyurek Y; Tunca F; Boztepe H; Alagöl F; Terzioglu T; Tezelman S
Surgery; 2009 Dec; 146(6):1188-95. PubMed ID: 19958948
[TBL] [Abstract][Full Text] [Related]
51. [Microscopic thyroid papillary cancers presenting as cervical lymph node metastases].
Emy P; Michenet P; Saint-Marc O
Ann Chir; 1998; 52(5):461-4. PubMed ID: 9752488
[TBL] [Abstract][Full Text] [Related]
52. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
Grigsby PW; Reddy RM; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients.
Zhang C; Li B; Zhang L; Chen F; Zhang Y; Cheng W
BMC Cancer; 2022 Apr; 22(1):354. PubMed ID: 35365120
[TBL] [Abstract][Full Text] [Related]
54. Well-differentiated thyroid carcinoma: comparison of microscopic and macroscopic disease.
Tzvetov G; Hirsch D; Shraga-Slutzky I; Weinstein R; Manistersky Y; Kalmanovich R; Lapidot M; Grozinsky-Glasberg S; Singer J; Sulkes J; Shimon I; Benbassat C
Thyroid; 2009 May; 19(5):487-94. PubMed ID: 19348580
[TBL] [Abstract][Full Text] [Related]
55. The absence of lymph nodes removed (pNx status) impacts survival in patients with lung cancer treated surgically.
Cackowski MM; Gryszko GM; Zbytniewski M; Dziedzic M; Woźnica K; Orłowski TM; Dziedzic DA;
Surg Oncol; 2023 Jun; 48():101941. PubMed ID: 37023511
[TBL] [Abstract][Full Text] [Related]
56. Clinical and economic outcomes associated with lymph node examination status in early-stage non-small cell lung cancer: a real-world US study using the SEER-Medicare linked database.
Lee JM; To TM; Wang S; Lin CW; Johnson A; Meyer CS; Lee JS
Transl Cancer Res; 2024 Apr; 13(4):1821-1833. PubMed ID: 38737679
[TBL] [Abstract][Full Text] [Related]
57. Microscopic extrathyroid extension in papillary thyroid carcinoma: impact on response to therapy.
Marques B; Martins RG; Couto J; Santos J; Martins T; Rodrigues F
Arch Endocrinol Metab; 2020 Apr; 64(2):144-149. PubMed ID: 32236308
[TBL] [Abstract][Full Text] [Related]
58. Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis.
Malandrino P; Russo M; Regalbuto C; Pellegriti G; Moleti M; Caff A; Squatrito S; Vigneri R
Thyroid; 2016 Sep; 26(9):1285-92. PubMed ID: 27349273
[TBL] [Abstract][Full Text] [Related]
59. The effect of the area proportion of the metastatic lesion within the central metastatic lymph node on response to therapy in papillary thyroid carcinoma.
Shi L; Zhou L; Wang J; Jin L; Lei Y; Xia L; Xie L
Oncol Lett; 2021 Apr; 21(4):284. PubMed ID: 33732360
[TBL] [Abstract][Full Text] [Related]
60. Clinical Implication of Node-negative Resectable Pancreatic Cancer.
Yamada M; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Aramaki T; Endo M; Uesaka K
Ann Surg Oncol; 2021 Apr; 28(4):2257-2264. PubMed ID: 33452602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
